| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hemodynamics and Vascular Regulation |




* Division of Endocrinology, Diabetes and Hypertension, and
Division of Cardiology, Department of Medicine, and the
Department of Radiology, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts; and
Division of Endocrinology and Metabolism, Henry Ford Hospital, Detroit, Michigan
Address correspondence to: Dr. Todd S. Perlstein, Brigham and Womens Hospital, Cardiovascular Division, 75 Francis Street, A Building, Boston, MA 02115. Phone: 617-545-7168; Fax: 617-264-5265; E-mail: tperlstein{at}partners.org
Received for publication September 20, 2006. Accepted for publication January 1, 2007.
Insulin stimulates the renin-angiotensin system and induces renal vasodilation. The relationship between these opposing influences of insulin on renal vascular tone has not been explored. A hyperinsulinemic euglycemic clamp and sham insulin clamp each of 270 min duration were performed in 15 healthy individuals during high sodium balance. An angiotensin receptor blocker was administered at time 180 min. Renal plasma flow and plasma renin activity were measured serially. The response to insulin or sham insulin infusion was defined as the change from time 0 to 180 min; the response to angiotensin receptor blockade (ARB) was defined as the change from time 180 to 270 min. Insulin infusion increased plasma renin activity (P < 0.01) and renal plasma flow (P < 0.01); the latter effect plateaued by time 150 min. ARB caused a greater vasodilator response during insulin infusion compared with during sham insulin infusion (P = 0.02). Increasing renin response to insulin predicted blunting of the renal vasodilator response to insulin infusion (R2 = 0.36, P = 0.02) and sensitizing of the renal vasodilator response to ARB during insulin infusion (R2 = 0.59, P < 0.01). Insulin-induced activation of the renin-angiotensin system modulates insulin-induced renal vasodilation in healthy individuals. Further studies are warranted to address this balance in states of insulin resistance and the possible implications for the association of insulin resistance with risk for chronic kidney disease.
Related Article
J. Am. Soc. Nephrol. 2007 18: 661-662.
This article has been cited by other articles:
![]() |
I. H. de Boer, B. Kestenbaum, T. C. Rue, M. W. Steffes, P. A. Cleary, M. E. Molitch, J. M. Lachin, N. S. Weiss, J. D. Brunzell, and for the Diabetes Control and Complications Trial ( Insulin Therapy, Hyperglycemia, and Hypertension in Type 1 Diabetes Mellitus Arch Intern Med, September 22, 2008; 168(17): 1867 - 1873. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ruan, F. Zheng, and Y. Guan PPARs and the kidney in metabolic syndrome Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1032 - F1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Isakova, O. Gutierrez, A. Shah, L. Castaldo, J. Holmes, H. Lee, and M. Wolf Postprandial Mineral Metabolism and Secondary Hyperparathyroidism in Early CKD J. Am. Soc. Nephrol., March 1, 2008; 19(3): 615 - 623. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673